
Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.
September 20, 2015
Drug for Early Alzheimer’s Heads to Clinical Trial
Johns Hopkins University researchers have received an estimated $7.5 million National Institutes of Health grant to clinically test what would be the first treatment to prevent or delay the onset of Alzheimer’s dementia.